On July 3, 2023, the U.S. Food and Drug Administration (FDA) issued a warning letter to Sunshine Trading Company, Inc., operating as Nova Tea and Nova Kratom, addressing multiple violations related to the marketing and safety of their products. The letter outlined concerns regarding the company’s failure to provide adequate evidence supporting the safety and efficacy of its kratom products, which have been associated with serious health risks. The FDA highlighted the lack of appropriate labeling and the promotion of unverified health claims that could mislead consumers. The agency mandated immediate corrective actions to ensure compliance with federal regulations and protect public health. The warning letter underscores the ongoing scrutiny of the kratom industry and the importance of regulatory oversight in safeguarding consumers from potentially harmful products.
Menu
